NEW YORK (GenomeWeb) – The University of Maryland, Baltimore and the University of Maryland, College Park have granted molecular diagnostics firm Cellth Systems an exclusive license to commercially develop a cell-tethering technology that allows for real-time analysis of circulating tumor cells.

Cellth also said today that TEDCO has awarded it $150,000 through the Maryland Innovation Initiative program, which will help advance the device toward commercialization.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.